Clinical Pharmacology and Drug Toxicity — MCQs

A patient with a positive tuberculin test (PPD) and a normal chest X-ray, who was treated with a 6-month course of prophylactic medication for tuberculosis exposure, subsequently developed peripheral neuropathies. Which one of the following vitamins would be considered a treatment for this neurotoxicity?

Q419Easy

What is the primary treatment for iron poisoning in a 4-year-old child?

Q420Medium

Which of the following is NOT caused by Magnesium Sulfate toxicity?

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 411: Non-oliguric acute renal failure is caused by which of the following drugs?

A. Aminoglycoside (Correct Answer)
B. Penicillin
C. Erythromycin
D. Ampicillin

Explanation: **Explanation:** **1. Why Aminoglycosides are correct:** Aminoglycosides (e.g., Gentamicin, Amikacin) are notorious for causing **dose-dependent nephrotoxicity**. They are filtered by the glomerulus and actively reabsorbed by the proximal convoluted tubule (PCT) cells, where they accumulate in lysosomes. This leads to tubular necrosis. Characteristically, this presents as **non-oliguric acute renal failure (ARF)**. In this condition, the glomerular filtration rate (GFR) drops, but the patient continues to produce a normal or even high volume of urine because the damaged tubules lose their ability to concentrate urine and reabsorb water. **2. Why the other options are incorrect:** * **Penicillin & Ampicillin:** While Penicillins can cause renal issues, they typically manifest as **Acute Interstitial Nephritis (AIN)**—an immune-mediated hypersensitivity reaction. This is characterized by fever, rash, eosinophilia, and eosinophiluria, rather than direct toxic non-oliguric tubular necrosis. * **Erythromycin:** This macrolide is primarily metabolized by the liver and excreted in bile. It is not associated with significant nephrotoxicity; its primary side effects are GI upset and cholestatic jaundice. **3. Clinical Pearls for NEET-PG:** * **Mechanism:** Aminoglycoside toxicity is due to accumulation in the renal cortex (PCT). * **Reversibility:** The damage is usually reversible if the drug is discontinued early. * **Monitoring:** Therapeutic Drug Monitoring (TDM) and monitoring serum creatinine are essential. * **Other causes of Non-oliguric ARF:** Amphotericin B, Cisplatin, and Methoxyflurane. * **Ototoxicity:** Remember that Aminoglycosides also cause irreversible ototoxicity (vestibular/cochlear damage).

Question 412: What is the treatment of choice for cyanide poisoning?

A. Sodium bicarbonate
B. Potassium permanganate
C. Sodium chloride
D. Sodium nitrite (Correct Answer)

Explanation: ### Explanation **Correct Option: D (Sodium nitrite)** Cyanide poisoning is a medical emergency where cyanide binds to the **ferric (Fe³⁺) iron** of **cytochrome oxidase a3** in the mitochondrial electron transport chain, halting aerobic respiration and causing cellular hypoxia. The mechanism of **Sodium nitrite** involves the induction of **methemoglobinemia**. Nitrites oxidize the ferrous iron (Fe²⁺) in hemoglobin to ferric iron (Fe³⁺), forming methemoglobin. Methemoglobin has a higher affinity for cyanide than cytochrome oxidase does. It "pulls" cyanide away from the mitochondria to form **cyanmethemoglobin**, thereby restoring cellular respiration. This is typically followed by **Sodium thiosulfate**, which converts cyanmethemoglobin into non-toxic **thiocyanate**, excreted by the kidneys. **Why other options are incorrect:** * **A. Sodium bicarbonate:** Used to treat metabolic acidosis (which occurs in cyanide poisoning) but is not the specific antidote. * **B. Potassium permanganate:** An oxidizing agent used for gastric lavage in certain alkaloid poisonings, but ineffective against systemic cyanide toxicity. * **C. Sodium chloride:** A standard crystalloid for fluid resuscitation; it has no pharmacological role in neutralizing cyanide. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Antidote Kit:** Includes Amyl nitrite (inhaled), Sodium nitrite (IV), and Sodium thiosulfate (IV). * **Modern DOC:** **Hydroxocobalamin** (Vitamin B12a) is now often preferred over nitrites because it does not reduce the oxygen-carrying capacity of blood (unlike methemoglobin induction). It binds cyanide to form **cyanocobalamin**. * **Clinical Sign:** "Cherry-red" skin discoloration and a characteristic **bitter almond odor** on the breath. * **Contraindication:** Avoid nitrites in patients with concurrent carbon monoxide poisoning (e.g., fire victims), as it further compromises oxygen delivery.

Question 413: Cyclosporine acts by inhibiting the proliferation of which of the following?

A. IL-1
B. IL-2 (Correct Answer)
C. IL-6
D. Macrophages

Explanation: **Explanation:** **Mechanism of Action (Why B is correct):** Cyclosporine is a potent immunosuppressant classified as a **Calcineurin Inhibitor**. Its primary mechanism involves binding to an intracellular protein called **Cyclophilin**. This Cyclosporine-Cyclophilin complex inhibits **Calcineurin**, a phosphatase required for the dephosphorylation of **NFAT** (Nuclear Factor of Activated T-cells). Without dephosphorylation, NFAT cannot enter the nucleus to promote the transcription of pro-inflammatory cytokines. The most critical result of this pathway inhibition is the **suppression of Interleukin-2 (IL-2) production**, which is the primary growth factor for T-cell proliferation and differentiation. **Analysis of Incorrect Options:** * **A & C (IL-1 and IL-6):** These are primarily pro-inflammatory cytokines produced by innate immune cells (like macrophages). While Cyclosporine has some downstream effects on the overall cytokine milieu, its specific molecular target is the T-cell-specific IL-2 pathway. * **D (Macrophages):** Cyclosporine specifically targets **T-lymphocytes** (helper T-cells). It does not significantly inhibit the proliferation of macrophages, which are part of the innate immune system. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Uses:** Prevention of graft-versus-host disease (GVHD) in organ transplants and treatment of autoimmune conditions like rheumatoid arthritis and psoriasis. * **Side Effects (The "H" Mnemonic):** **H**ypertension, **H**yperplasia of gums (gingival hyperplasia), **H**irsutism, and **H**yperlipidemia. * **Major Toxicity:** **Nephrotoxicity** is the most common and dose-limiting side effect. * **Drug Interactions:** It is metabolized by **CYP3A4**; therefore, grapefruit juice (inhibitor) can increase its toxicity, while Rifampicin (inducer) can decrease its efficacy.

Question 414: What is the most common side effect of mycophenolate mofetil?

A. Marrow suppression
B. Nephrotoxicity
C. Diarrhea (Correct Answer)
D. Glucose intolerance

Explanation: **Explanation:** **Mycophenolate Mofetil (MMM)** is a potent immunosuppressant that acts by inhibiting **Inosine Monophosphate Dehydrogenase (IMPDH)**, the rate-limiting enzyme in the *de novo* synthesis of guanosine nucleotides. Since T and B lymphocytes lack the salvage pathway for purine synthesis, they are selectively inhibited. **1. Why Diarrhea is the Correct Answer:** Gastrointestinal (GI) disturbances are the most frequent adverse effects of MMF. Among these, **diarrhea** is the most common (occurring in up to 30-50% of patients), followed by nausea, vomiting, and abdominal pain. This occurs because MMF exerts a direct toxic effect on the rapidly dividing intestinal epithelial cells, which, like lymphocytes, are partially dependent on the *de novo* purine pathway. **2. Why Other Options are Incorrect:** * **Marrow suppression (A):** While MMF can cause leukopenia and anemia, it is generally considered less myelosuppressive than Azathioprine. GI toxicity remains more prevalent. * **Nephrotoxicity (B):** MMF is notably **non-nephrotoxic**. This is a major clinical advantage over Calcineurin Inhibitors (CNIs) like Cyclosporine and Tacrolimus. * **Glucose intolerance (C):** This is a classic side effect of Corticosteroids and Tacrolimus, not MMF. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Reversible inhibition of IMPDH. * **Clinical Use:** Prophylaxis of transplant rejection (often replacing Azathioprine) and treatment of Lupus Nephritis. * **Teratogenicity:** MMF is highly teratogenic (Category D); it is associated with **congenital malformations** (ear and facial defects). * **Drug Interaction:** Antacids containing magnesium or aluminum hydroxide decrease MMF absorption.

Question 415: Which of the following is NOT an immunomodulator?

A. Tacrolimus
B. Cyclosporin
C. Cycloserine (Correct Answer)
D. Sirolimus

Explanation: **Explanation:** The correct answer is **Cycloserine** because it is an **antitubercular antibiotic**, not an immunomodulator. **1. Why Cycloserine is the correct answer:** Cycloserine is a second-line drug used in the treatment of multi-drug-resistant tuberculosis (MDR-TB). It acts by inhibiting the enzymes **D-alanine synthetase** and **alanine racemase**, thereby preventing bacterial cell wall synthesis. It has no primary role in modulating the immune system. **2. Why the other options are incorrect:** * **Tacrolimus (A) & Cyclosporin (B):** Both are **Calcineurin Inhibitors**. They bind to specific cytoplasmic proteins (FKBP-12 for Tacrolimus; Cyclophilin for Cyclosporin) to inhibit calcineurin. This prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), leading to decreased production of IL-2 and other cytokines. * **Sirolimus (D):** Also known as Rapamycin, it is an **mTOR inhibitor**. It binds to FKBP-12 but, unlike Tacrolimus, it inhibits the "Mammalian Target of Rapamycin" (mTOR) pathway, blocking the cell cycle of T-cells in the G1-S phase. **Clinical Pearls for NEET-PG:** * **Cycloserine Side Effects:** Notable for **neurotoxicity** (seizures, psychosis). Pyridoxine (Vit B6) is often co-administered to reduce these effects. * **Gingival Hyperplasia:** A classic side effect of **Cyclosporin**, but notably **not** seen with Tacrolimus. * **Nephrotoxicity:** Both Cyclosporin and Tacrolimus are nephrotoxic, whereas Sirolimus is relatively non-nephrotoxic but can cause **hyperlipidemia and thrombocytopenia**. * **Drug of Choice:** Tacrolimus is generally preferred over Cyclosporin in solid organ transplantation due to higher potency and a better side-effect profile.

Question 416: Dimercaprol is contraindicated in poisoning with which of the following?

A. Iron (Correct Answer)
B. Mercury
C. Gold
D. Silver

Explanation: **Explanation:** **Dimercaprol (British Anti-Lewisite or BAL)** is a chelating agent containing sulfhydryl (-SH) groups that bind to heavy metals. However, its use is strictly contraindicated in **Iron (Option A)** poisoning. **Why Iron is the correct answer:** When Dimercaprol binds with iron, it forms a **Dimercaprol-Iron complex** that is highly **nephrotoxic**. Instead of safely eliminating the metal, this complex causes severe damage to the renal tubules. For iron toxicity, the specific chelator of choice is **Deferoxamine**. **Analysis of Incorrect Options:** * **Mercury (Option B):** Dimercaprol is a primary treatment for acute poisoning with inorganic mercury salts. * **Gold (Option C):** It is the drug of choice for treating toxicity resulting from gold salts (often used historically in rheumatoid arthritis). * **Silver (Option D):** While silver toxicity (Argyria) is rare and usually doesn't require chelation, Dimercaprol is not contraindicated for it in the same way it is for iron. **High-Yield Clinical Pearls for NEET-PG:** 1. **Contraindications:** Dimercaprol is also contraindicated in **Cadmium** poisoning (causes nephrotoxicity) and in patients with **G6PD deficiency** (causes hemolysis). 2. **Route of Administration:** It is highly lipid-soluble and must be administered via **deep intramuscular (IM)** injection. It has a pungent, garlic-like odor. 3. **Arsenic:** It remains the traditional first-line chelator for acute arsenic poisoning. 4. **Lead:** In severe lead encephalopathy, Dimercaprol is used **in combination with EDTA**.

Question 417: Extrahepatic manifestations such as fever, arthralgia, rash, and eosinophilia are typically seen with which type of drug-induced liver injury?

A. Direct toxic
B. Idiosyncratic (Correct Answer)
C. Cholestatic
D. Hepatocellular

Explanation: **Explanation:** Drug-induced liver injury (DILI) is broadly classified into two categories: **Intrinsic (Direct)** and **Idiosyncratic**. **1. Why Idiosyncratic is Correct:** Idiosyncratic DILI occurs in susceptible individuals and is not dose-dependent. It is often mediated by an **immuno-allergic mechanism** (Type B reaction). Because it involves a hypersensitivity response, it is frequently accompanied by systemic "extrahepatic" features such as **fever, rash, arthralgia, and peripheral eosinophilia**. This constellation of symptoms is a classic hallmark of hypersensitivity-type idiosyncratic injury. Common culprits include Phenytoin, Halothane, and Sulfonamides. **2. Why the other options are incorrect:** * **Direct Toxic (Intrinsic):** This is dose-dependent and predictable (e.g., Paracetamol toxicity). It occurs shortly after ingestion and typically lacks systemic allergic features like rash or eosinophilia. * **Cholestatic vs. Hepatocellular:** These terms describe the *pattern* of injury (biochemical profile) rather than the *mechanism*. While idiosyncratic reactions can present with either a cholestatic (e.g., Chlorpromazine) or hepatocellular (e.g., Isoniazid) pattern, the presence of systemic allergic features specifically points toward the **idiosyncratic/immuno-allergic mechanism** rather than the pattern itself. **Clinical Pearls for NEET-PG:** * **Latency:** Idiosyncratic reactions have a variable latency period (weeks to months), whereas direct toxins act within hours to days. * **Metabolic Idiosyncrasy:** Not all idiosyncratic reactions are allergic; some are due to abnormal metabolites (e.g., Isoniazid), which may *not* show fever or rash. * **High-Yield Example:** **Halothane** hepatitis is a classic idiosyncratic reaction often associated with eosinophilia and fever.

Question 418: A patient with a positive tuberculin test (PPD) and a normal chest X-ray, who was treated with a 6-month course of prophylactic medication for tuberculosis exposure, subsequently developed peripheral neuropathies. Which one of the following vitamins would be considered a treatment for this neurotoxicity?

A. Vitamin B1
B. Vitamin B2
C. Vitamin B3
D. Vitamin B6 (Correct Answer)

Explanation: ### Explanation **Correct Option: D (Vitamin B6 / Pyridoxine)** **Medical Concept:** The patient has Latent Tuberculosis Infection (LTBI), indicated by a positive PPD and normal chest X-ray. The standard prophylactic drug for LTBI is **Isoniazid (INH)**. INH causes peripheral neuropathy through two mechanisms: 1. It inhibits the enzyme **pyridoxine phosphokinase**, preventing the conversion of Vitamin B6 to its active form, pyridoxal-5-phosphate (PLP). 2. It reacts with Vitamin B6 to form **isonicotinyl-hydrazone**, which is excreted in the urine, leading to a functional deficiency. Since PLP is essential for the synthesis of neurotransmitters (like GABA), its deficiency results in nerve damage. Supplementing with **Vitamin B6** bypasses this inhibition and reverses the toxicity. **Analysis of Incorrect Options:** * **A. Vitamin B1 (Thiamine):** Deficiency causes Beriberi (Dry/Wet) and Wernicke-Korsakoff syndrome, typically seen in chronic alcoholism, not INH therapy. * **B. Vitamin B2 (Riboflavin):** Deficiency leads to cheilosis, glossitis, and corneal neovascularization. * **C. Vitamin B3 (Niacin):** Deficiency causes Pellagra (Dermatitis, Diarrhea, Dementia). While INH can theoretically cause Pellagra by interfering with Tryptophan metabolism, the primary cause of *peripheral neuropathy* in this context is Vitamin B6 deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 10–50 mg/day of Vitamin B6 is given to high-risk patients (diabetics, alcoholics, pregnant women, malnourished) starting INH to *prevent* neuropathy. * **Therapeutic Dose:** Higher doses (100–200 mg/day) are used to *treat* established neuropathy. * **Sideroblastic Anemia:** INH can also cause this because Vitamin B6 is a cofactor for ALA synthase (the rate-limiting step in heme synthesis). * **Slow Acetylators:** Patients who are "slow acetylators" of INH are at a much higher risk for this neurotoxicity.

Question 419: What is the primary treatment for iron poisoning in a 4-year-old child?

A. Gastric lavage
B. Deferoxamine administered intravenously (Correct Answer)
C. X-ray of the abdomen
D. Blood transfusion

Explanation: ### Explanation **Correct Option: B. Deferoxamine administered intravenously** Iron poisoning is a medical emergency in children, often due to the ingestion of colorful prenatal vitamins. **Deferoxamine** is the specific parenteral chelating agent of choice. It binds to ferric iron ($Fe^{3+}$) to form **ferrioxamine**, a water-soluble complex excreted by the kidneys. Intravenous administration is preferred over intramuscular in symptomatic patients to ensure rapid systemic availability, especially if the child is in shock. A classic sign of successful chelation is **"vin-rose" colored urine** (reddish-pink). **Why Incorrect Options are Wrong:** * **A. Gastric Lavage:** While it may be considered within 1 hour of ingestion, it is often ineffective because iron tablets are large and frequently clump together (forming radiopaque masses). Furthermore, standard activated charcoal does **not** bind iron. * **C. X-ray of the Abdomen:** This is a diagnostic tool, not a treatment. Since iron tablets are radiopaque, an X-ray helps confirm ingestion and estimate the pill burden, but it does not address the toxicity. * **D. Blood Transfusion:** This is not a primary treatment for iron poisoning. While iron causes gastrointestinal bleeding and shock, the priority is chelation and fluid resuscitation. **NEET-PG High-Yield Pearls:** * **Mechanism of Toxicity:** Iron causes direct mucosal damage (GI bleed) and systemic mitochondrial toxicity (metabolic acidosis). * **Oral Chelator:** **Deferasirox** and **Deferiprone** are used for *chronic* iron overload (e.g., Thalassemia), but **Deferoxamine** (IV) is the gold standard for *acute* poisoning. * **Whole Bowel Irrigation (WBI):** Using Polyethylene Glycol (PEG) is the preferred decontamination method for iron, as charcoal is ineffective. * **Lethal Dose:** Ingestion of >60 mg/kg of elemental iron is considered potentially life-threatening.

Question 420: Which of the following is NOT caused by Magnesium Sulfate toxicity?

A. Cardiotoxicity (Correct Answer)
B. Renal failure
C. Respiratory depression
D. Abnormal deep tendon reflexes

Explanation: **Explanation:** Magnesium Sulfate ($MgSO_4$) is the drug of choice for managing eclampsia and pre-eclampsia. Toxicity occurs when serum magnesium levels exceed the therapeutic range (4–7 mEq/L). **Why Cardiotoxicity is the Correct Answer:** While $MgSO_4$ can cause cardiac effects like bradycardia or cardiac arrest at extremely high levels (>15 mEq/L), it is **not** typically associated with **renal failure**. In fact, the relationship is the reverse: **Renal failure is a cause of Magnesium toxicity**, not a result of it. Since $MgSO_4$ is excreted almost entirely by the kidneys, any pre-existing renal impairment leads to the accumulation of the drug, triggering toxicity. **Analysis of Other Options:** * **Abnormal Deep Tendon Reflexes (DTRs):** This is the **earliest sign** of toxicity (occurring at 7–10 mEq/L). Loss of the patellar reflex (hyporeflexia) serves as a critical clinical warning to stop the infusion. * **Respiratory Depression:** As levels rise (10–12 mEq/L), magnesium acts as a neuromuscular blocker, leading to paralysis of respiratory muscles and respiratory depression. * **Cardiotoxicity:** At very high levels (>15 mEq/L), it causes conduction delays and eventual cardiac arrest. However, in the context of this question, "Renal Failure" is the distinct outlier as it is the *predisposing factor* rather than a *toxic effect*. **NEET-PG High-Yield Pearls:** 1. **Monitoring:** Always check three parameters before/during $MgSO_4$ administration: **Patellar reflex** (present), **Respiratory rate** (>12-16/min), and **Urine output** (>30 ml/hr). 2. **Antidote:** The specific antidote for Magnesium toxicity is **10% Calcium Gluconate** (10 ml IV over 10 minutes). 3. **Therapeutic Window:** 4–7 mEq/L. Loss of DTRs occurs at >7 mEq/L; Respiratory paralysis at >10 mEq/L.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free